JOURNAL ONKOLOGIE – STUDIE
Determination of Drugs and Their Metabolites in Hospitalized Patients
Rekrutierend
NCT-Nummer:
NCT01702545
Studienbeginn:
August 2012
Letztes Update:
02.09.2020
Wirkstoff:
-
Geschlecht:
Alle
Altersgruppe:
Erwachsene (18+)
Phase:
-
Sponsor:
Klinikum Nürnberg
Collaborator:
-
Studienleiter
Study Chair
Paracelsus Medical University Klinikum Nuremberg, Germany
Kontakt
Kontakt:
Phone: 00499113983050
E-Mail: martin.wilhelm@klinikum-nuernberg.de» Kontaktdaten anzeigen
Kontakt:
Phone: 00499113983050
E-Mail: martin.wilhelm@klinikum-nuernberg.de» Kontaktdaten anzeigen
Studienlocations (1 von 1)
Dept. of Internal Medicine V, Klinikum Nürnberg Nord
90419 Nürnberg
(Bayern)
GermanyRekrutierend» Google-Maps
Ansprechpartner:
Martin Wilhelm, Prof. Dr.
Phone: 00499113983050
E-Mail: martin.wilhelm@klinikum-nuernberg.de» Ansprechpartner anzeigen
90419 Nürnberg
(Bayern)
GermanyRekrutierend» Google-Maps
Ansprechpartner:
Martin Wilhelm, Prof. Dr.
Phone: 00499113983050
E-Mail: martin.wilhelm@klinikum-nuernberg.de» Ansprechpartner anzeigen
Studien-Informationen
Detailed Description:The primary goal of the study is to gain an overview of the plasma concentrations of relevant drugs which occur in different patient populations and to what extent they are consistent with those concentrations described in the literature.
If the expectation is confirmed, that a significant heterogeneity in the plasma concentrations of these patients exists, the investigators will try to find influencing factors for this circumstance on the basis of routine clinical parameters (height, weight, renal function, concomitant medications, etc.).
Ultimately, this project will identify substances with a high interindividual variability in plasma levels, where drug monitoring might be suggested.
Ein-/Ausschlusskriterien
Inclusion Criteria:- legal capacity
Exclusion Criteria:
- severe anemia
Studien-Rationale
Primary outcome:1. Plasma concentrations [ng/mL] of various drugs at different timepoints (Time Frame - up to five years)
Quelle: ClinicalTrials.gov